{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T09:05:58Z","timestamp":1786871158471,"version":"build-2736575974"},"reference-count":93,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2020,1,10]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>The mucosal surfaces of the body are characterised by complex, specialised microbial communities, often referred to as the <jats:italic>microbiome<\/jats:italic>. However, only much more recently\u2014with the development of technologies allowing exploration of the composition and functionality of these communities\u2014has meaningful research in this area become feasible. Over the past few years, there has been rapid growth in interest in the gut microbiome in particular, and its potential contribution to gastrointestinal and liver disease. This interest has already extended beyond clinicians to pharmaceutical companies, medical regulators and other stakeholders, and is high profile among patients and the lay public in general. Such expansion of knowledge holds the intriguing potential for translation into novel diagnostics and therapeutics; however, being such a nascent field, there remain many uncertainties, unanswered questions and areas of debate.<\/jats:p>","DOI":"10.1136\/flgastro-2019-101376","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T17:15:45Z","timestamp":1580836545000},"page":"118-127","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["The gut microbiome: what every gastroenterologist needs to know"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6300-3100","authenticated-orcid":false,"given":"Benjamin H","family":"Mullish","sequence":"first","affiliation":[{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College of Science Technology and Medicine, London, UK"},{"name":"Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Nabil","family":"Quraishi","sequence":"additional","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre, University of Birmingham, Birmingham, UK"},{"name":"Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9668-0316","authenticated-orcid":false,"given":"Jonathan P","family":"Segal","sequence":"additional","affiliation":[{"name":"Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Ianiro","sequence":"additional","affiliation":[{"name":"Digestive Disease Centre, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Gemelli, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq H","family":"Iqbal","sequence":"additional","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre, University of Birmingham, Birmingham, UK"},{"name":"Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,2,4]]},"reference":[{"key":"2025090709305912000_12.2.118.1","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-015-0094-5"},{"key":"2025090709305912000_12.2.118.2","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818822250","article-title":"The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease","volume":"12","author":"Segal","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"2025090709305912000_12.2.118.3","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2018.864","article-title":"The implementation of omics technologies in cancer microbiome research","volume":"12","author":"Mullish","year":"2018","journal-title":"Ecancermedicalscience"},{"key":"2025090709305912000_12.2.118.4","doi-asserted-by":"publisher","DOI":"10.3402\/mehd.v26.26050"},{"key":"2025090709305912000_12.2.118.5","doi-asserted-by":"crossref","unstructured":"Gritz EC , Bhandari V . The human neonatal gut microbiome: a brief review. Front Pediatr 2015;3.","DOI":"10.3389\/fped.2015.00017"},{"key":"2025090709305912000_12.2.118.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2018.09.008"},{"key":"2025090709305912000_12.2.118.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0061-2"},{"key":"2025090709305912000_12.2.118.8","doi-asserted-by":"crossref","unstructured":"Francino MP . Antibiotics and the human gut microbiome: Dysbioses and accumulation of resistances. Front Microbiol 2016;6.doi:10.3389\/fmicb.2015.01543","DOI":"10.3389\/fmicb.2015.01543"},{"key":"2025090709305912000_12.2.118.9","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.041640"},{"key":"2025090709305912000_12.2.118.10","doi-asserted-by":"publisher","DOI":"10.1038\/nature12820"},{"key":"2025090709305912000_12.2.118.11","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.42"},{"key":"2025090709305912000_12.2.118.12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.223594"},{"key":"2025090709305912000_12.2.118.13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41564-018-0278-4","article-title":"The role of the microbiota in infectious diseases","volume":"4","author":"Libertucci","year":"2019","journal-title":"Nat Microbiol"},{"key":"2025090709305912000_12.2.118.14","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.130"},{"key":"2025090709305912000_12.2.118.15","doi-asserted-by":"crossref","unstructured":"Wilkins LJ , Monga M , Miller AW . Defining dysbiosis for a cluster of chronic diseases. Sci Rep 2019;9.doi:10.1038\/s41598-019-49452-y","DOI":"10.1038\/s41598-019-49452-y"},{"key":"2025090709305912000_12.2.118.16","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuw047"},{"key":"2025090709305912000_12.2.118.17","doi-asserted-by":"publisher","DOI":"10.1038\/nature09199"},{"key":"2025090709305912000_12.2.118.18","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181c87e02"},{"key":"2025090709305912000_12.2.118.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0706625104"},{"key":"2025090709305912000_12.2.118.20","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol"},{"key":"2025090709305912000_12.2.118.21","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01004-06"},{"key":"2025090709305912000_12.2.118.22","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20903"},{"key":"2025090709305912000_12.2.118.23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304833"},{"key":"2025090709305912000_12.2.118.24","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12365"},{"key":"2025090709305912000_12.2.118.25","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20783"},{"key":"2025090709305912000_12.2.118.26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2002.02834.x"},{"key":"2025090709305912000_12.2.118.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2014.02.005"},{"key":"2025090709305912000_12.2.118.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.12.015"},{"key":"2025090709305912000_12.2.118.29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/apt.13905","article-title":"Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm","volume":"45","author":"Segal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709305912000_12.2.118.30","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21039"},{"key":"2025090709305912000_12.2.118.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2008.12.003"},{"key":"2025090709305912000_12.2.118.32","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.05.041"},{"key":"2025090709305912000_12.2.118.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066934","article-title":"Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis","volume":"8","author":"Tyler","year":"2013","journal-title":"PLoS One"},{"key":"2025090709305912000_12.2.118.34","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309398"},{"key":"2025090709305912000_12.2.118.35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/apt.14454","article-title":"Systematic review: ileoanal pouch microbiota in health and disease","volume":"47","author":"Segal","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709305912000_12.2.118.36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.trsl.2016.07.005","article-title":"Gut microbiome and liver disease","volume":"179","author":"Betrapally","year":"2017","journal-title":"Translational Research"},{"key":"2025090709305912000_12.2.118.37","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"2025090709305912000_12.2.118.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1742-x"},{"key":"2025090709305912000_12.2.118.39","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00338.2016"},{"key":"2025090709305912000_12.2.118.40","doi-asserted-by":"crossref","unstructured":"Hugerth LW , Andreasson A , Talley NJ , et al . No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population. Gut 2019. doi:doi:10.1136\/gutjnl-2019-318717. [Epub ahead of print: 10 Oct 2019].","DOI":"10.1136\/gutjnl-2019-318717"},{"key":"2025090709305912000_12.2.118.41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.21037\/jlpm.2018.09.05","article-title":"Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology","volume":"3","author":"Kosumi","year":"2018","journal-title":"J Lab Precis Med"},{"key":"2025090709305912000_12.2.118.42","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-102215-095513"},{"key":"2025090709305912000_12.2.118.43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/jamaoncol.2015.1377","article-title":"Fusobacterium nucleatum and T Cells in Colorectal Carcinoma","volume":"1","author":"Mima","year":"2015","journal-title":"JAMA Oncol"},{"key":"2025090709305912000_12.2.118.44","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310101"},{"key":"2025090709305912000_12.2.118.45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bpg.2017.09.011","article-title":"Action and function of Faecalibacterium prausnitzii in health and disease","volume":"31","author":"Ferreira-Halder","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2025090709305912000_12.2.118.46","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2018.289728"},{"key":"2025090709305912000_12.2.118.47","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4255"},{"key":"2025090709305912000_12.2.118.48","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.20"},{"key":"2025090709305912000_12.2.118.49","doi-asserted-by":"crossref","unstructured":"Fessas P , Possamai LA , Clark J , et al . Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms. Immunology 2019;13141.","DOI":"10.1111\/imm.13141"},{"key":"2025090709305912000_12.2.118.50","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706"},{"key":"2025090709305912000_12.2.118.51","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao3290"},{"key":"2025090709305912000_12.2.118.52","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4236"},{"key":"2025090709305912000_12.2.118.53","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0238-9"},{"key":"2025090709305912000_12.2.118.54","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313750"},{"key":"2025090709305912000_12.2.118.55","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1053\/j.gastro.2018.12.002","article-title":"Treatment of Active Crohn\u2019s Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition","volume":"156","author":"Svolos","year":"2019","journal-title":"Gastroenterology"},{"key":"2025090709305912000_12.2.118.56","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/137.3.830S"},{"key":"2025090709305912000_12.2.118.57","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.75"},{"key":"2025090709305912000_12.2.118.58","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/125.6.1401"},{"key":"2025090709305912000_12.2.118.59","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000183421.02316.d5"},{"key":"2025090709305912000_12.2.118.60","doi-asserted-by":"publisher","DOI":"10.1080\/10408390500215746"},{"key":"2025090709305912000_12.2.118.61","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/ibd\/izz188","article-title":"Systematic review and meta-analysis: short-chain fatty acid characterization in patients with inflammatory bowel disease","volume":"25","author":"Zhuang","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2025090709305912000_12.2.118.62","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.117"},{"key":"2025090709305912000_12.2.118.63","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.3748\/wjg.v21.i19.5985","article-title":"Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis","volume":"21","author":"Yoshimatsu","year":"2015","journal-title":"WJG"},{"key":"2025090709305912000_12.2.118.64","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318484"},{"key":"2025090709305912000_12.2.118.65","doi-asserted-by":"publisher","DOI":"10.1136\/gut.53.1.108"},{"key":"2025090709305912000_12.2.118.66","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709305912000_12.2.118.67","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0084-x"},{"key":"2025090709305912000_12.2.118.68","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14201"},{"key":"2025090709305912000_12.2.118.69","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.019"},{"key":"2025090709305912000_12.2.118.70","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.482"},{"key":"2025090709305912000_12.2.118.71","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17077"},{"key":"2025090709305912000_12.2.118.72","unstructured":"Faecal microbiota TR faecal microbiota transplant for recurrent ansplant for recurrent Clostridium difficile infection Clostridium difficile infection interventional procedure guidance, 2014. Available: https:\/\/www.nice.org.uk\/guidance\/ipg485\/resources\/faecal-microbiota-transplant-for-recurrent-clostridium-difficile-infection-1899869993554885 [Accessed 20 Mar 2017]."},{"key":"2025090709305912000_12.2.118.73","unstructured":"Public Health England . Updated guidance on the management and treatment of Clostridium difficile infection. Public Heal Engl 2013:1\u201329 https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/321891\/Clostridium_difficile_management_and_treatment.pdf (accessed 20 Mar 2017)."},{"key":"2025090709305912000_12.2.118.74","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316818"},{"key":"2025090709305912000_12.2.118.75","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12427"},{"key":"2025090709305912000_12.2.118.76","first-page":"431","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases Society of America (IDSA) and Society for healthcare epidemiology of America (SheA)","volume":"31","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025090709305912000_12.2.118.77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910437"},{"key":"2025090709305912000_12.2.118.78","doi-asserted-by":"crossref","unstructured":"Terveer EM , van Gool T , Ooijevaar RE , et al . Human transmission of Blastocystis by fecal microbiota transplantation without development of gastrointestinal symptoms in recipients. Clin Infect Dis 2019. doi:doi:10.1093\/cid\/ciz1122. [Epub ahead of print: 15 Nov 2019].","DOI":"10.1093\/cid\/ciz1122"},{"key":"2025090709305912000_12.2.118.79","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319548"},{"key":"2025090709305912000_12.2.118.80","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(19)31266-8","article-title":"The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications","volume":"394","author":"Allegretti","year":"2019","journal-title":"The Lancet"},{"key":"2025090709305912000_12.2.118.81","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14173"},{"key":"2025090709305912000_12.2.118.82","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"key":"2025090709305912000_12.2.118.83","doi-asserted-by":"crossref","unstructured":"Quraishi MNN , Yalchin M , Blackwell C , et al . STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis. BMJ Open 2019;9.","DOI":"10.1136\/bmjopen-2019-030659"},{"key":"2025090709305912000_12.2.118.84","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.15330","article-title":"Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome","volume":"50","author":"Ianiro","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709305912000_12.2.118.85","doi-asserted-by":"crossref","unstructured":"El-Salhy M , Hatlebakk JG , Gilja OH , et al . Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 2019. doi:doi:10.1136\/gutjnl-2019-319630. [Epub ahead of print: 18 Dec 2019].","DOI":"10.1136\/gutjnl-2019-319630"},{"key":"2025090709305912000_12.2.118.86","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023518","article-title":"Profit, a prospective, randomised placebo controlled feasibility trial of faecal mIcrobiota transplantation in cirrhosis: study protocol for a single-blinded trial","volume":"9","author":"Woodhouse","year":"2019","journal-title":"BMJ Open"},{"key":"2025090709305912000_12.2.118.87","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"2025090709305912000_12.2.118.88","doi-asserted-by":"crossref","unstructured":"Allegretti JR , Kassam Z , Mullish BH , et al . Effects of fecal microbiota transplantation with oral capsules in obese patients. Clinical Gastroenterology and Hepatology 2019. doi:doi:10.1016\/j.cgh.2019.07.006. [Epub ahead of print: 10 Jul 2019].","DOI":"10.1016\/j.cgh.2019.07.006"},{"key":"2025090709305912000_12.2.118.89","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.06.031"},{"key":"2025090709305912000_12.2.118.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.06.016"},{"key":"2025090709305912000_12.2.118.91","doi-asserted-by":"crossref","unstructured":"de Groot P , Scheithauer T , Bakker GJ , et al . Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time. Gut 2019. doi:doi:10.1136\/gutjnl-2019-318320. [Epub ahead of print: 30 May 2019].","DOI":"10.1136\/gutjnl-2019-318320"},{"key":"2025090709305912000_12.2.118.92","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0225-7"},{"key":"2025090709305912000_12.2.118.93","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cmi.2018.12.009","article-title":"A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial","volume":"25","author":"Huttner","year":"2019","journal-title":"Clin Microbiol Infect"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2019-101376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:31:14Z","timestamp":1757262674000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2019-101376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,4]]},"references-count":93,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,5]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/flgastro-2019-101376"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2019-101376","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,4]]}}}